Literature DB >> 316979

Effects of thymosin in vitro in cancer patients and correlation with clinical course after thymosin immunotherapy.

P B Chretien, S D Lipson, R W Makuch, D E Kenady, M H Cohen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 316979     DOI： 10.1111/j.1749-6632.1979.tb47107.x

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN： 0077-8923            Impact factor:   5.691


× No keyword cloud information.
  6 in total

1.  Primary structure of rat thymus prothymosin alpha.

Authors:  A A Haritos; R Blacher; S Stein; J Caldarella; B L Horecker
Journal:  Proc Natl Acad Sci U S A       Date:  1985-01       Impact factor: 11.205

2.  Immunomodulation and therapeutic characterization of thymosin fraction five.

Authors:  J E Talmadge; K A Uithoven; B F Lenz; M Chirigos
Journal:  Cancer Immunol Immunother       Date:  1984       Impact factor: 6.968

3.  Thymosin increases production of T-cell growth factor by normal human peripheral blood lymphocytes.

Authors:  M M Zatz; J Oliver; C Samuels; A B Skotnicki; M B Sztein; A L Goldstein
Journal:  Proc Natl Acad Sci U S A       Date:  1984-05       Impact factor: 11.205

4.  Pathogenesis of Mooren's ulcer: some new concepts.

Authors:  P I Murray; A H Rahi
Journal:  Br J Ophthalmol       Date:  1984-03       Impact factor: 4.638

5.  Thymus lymphocytes in uraemic rats and the effect of thymosin fraction 5 in vivo.

Authors:  S Ikemoto; M Kamizuru; N Hayahara; S Okamoto; S Wada; T Kishimoto; M Maekawa
Journal:  Clin Exp Immunol       Date:  1992-02       Impact factor: 4.330

6.  Randomized phase II clinical trial of chemo-immunotherapy in advanced nonsmall cell lung cancer.

Authors:  Eduardo Lasalvia-Prisco; Emilio Garcia-Giralt; Jesús Vázquez; Marta Aghazarian; Eduardo Lasalvia-Galante; Joshemaria Larrañaga; Gonzalo Spera
Journal:  Biologics       Date:  2008-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.